PSI Structural Biology Knowledgebase

PSI | Structural Biology Knowledgebase
Header Icons
E-Collection

Related Articles
Drug Discovery: Solving the Structure of an Anti-hypertension Drug Target
July 2015
Retrospective: 7,000 Structures Closer to Understanding Biology
July 2015
Design and Evolution: Bespoke Design of Repeat Proteins
June 2015
Design and Evolution: Tunable Antibody Binders
June 2015
Immunity: Clustering Immunoglobulins
June 2014
Immunity: Conformational Capture
June 2014
Immunity: One Antibody to Rule Them All
June 2014
Immunity: Tissue Contribution
June 2014
Caught in the Act
December 2013
Serum Albumins and Allergies
October 2013
The Immune System: A Brotherhood of Immunoglobulins
June 2013
The Immune System: A Strong Competitor
June 2013
The Immune System: Strand Swapping for T-Cell Inhibition
June 2013
The Immune System: Super Cytokines
June 2013
Tuning Immune Response with Costimulation
June 2013
Regulatory insights
September 2012
Serum albumin diversity
August 2012
Substrate specificity sleuths
April 2012
Buena VISTA
February 2012
Analyzing an allergen
January 2012
TLR4 regulation: heads or tails?
October 2011
Binding complement with complementarity
June 2011

Research Themes Immunology

Analyzing an allergen

SBKB [doi:10.1038/sbkb.2011.57]
Featured Article - January 2012
Short description: Computational, structural, and biochemical analysis of peanut Ara h 1 gives insights into understanding and diagnosing nut allergies.

A molecular surface representation of the trimeric Ara h 1 core. Figure courtesy of Wladek Minor.

As the incidence of peanut and tree nut allergies rises, pressure is mounting on researchers to understand the mechanisms behind these allergies and provide improved diagnostics and treatments. The two major peanut allergens are the vicilin Ara h 1 and the legumin Ara h 3. Ara h 1 is recognized by IgE present in sera from 90% of peanut-allergic individuals. It forms a homotrimer and may form larger oligomers in vivo. How the natural form of peanut Ara h 1 compares to other nut allergens and to recombinant Ara h 1 that can be used in newly developed diagnostic methods remains to be seen.

Minor, Chruszcz and colleagues (PSI NYSGRC) have performed a multifaceted analysis of natural and recombinant peanut Ara h 1. Crystallographic data reveal that the recombinant Ara h 1 core is trimeric and sufficient for formation of larger oligomers. Small angle X-ray scattering data indicate that natural Ara h 1 as well as the recombinant core form larger oligomers containing 9 or 12 protein chains. Interestingly, the full-length recombinant form of Ara h 1 is monomeric and partially unfolded in solution, consistent with in vitro gastric digestion assays that revealed natural Ara h 1 is most stable while full-length recombinant Ara h 1 is least stable. When tested for reactivity to serum IgE from patients with a peanut allergy, full-length recombinant Ara h 1 was reactive for most individuals, although natural Ara h 1 was reactive for all patients and usually produced a stronger reaction than recombinant Ara h 1. The shortened recombinant core of Ara h 1 also reacted with patient sera, with a pattern similar to that of full-length recombinant Ara h 1.

The authors find strong sequence and structural similarities between Ara h 1 and other vicilins and legumins, consistent with previously reported shared IgE-binding epitopes between peanuts and tree nut allergens; this helps explain how patients with peanut allergies often have allergies to other nuts as well. However, the finding that recombinant Ara h 1 was not recognized by patient sera as strongly as natural Ara h 1 has important clinical implications, and the differences between recombinant and natural Ara h 1 reported here need to be taken into account in the refinement of new diagnostic methods.

Steve Mason

References

  1. M. Chruszcz et al. Structural and Immunologic Characterization of Ara h 1, a Major Peanut Allergen.
    J. Biol. Chem. 286, 39318-39327 (2011). doi:10.1074/jbc.M111.270132

Structural Biology Knowledgebase ISSN: 1758-1338
Funded by a grant from the National Institute of General Medical Sciences of the National Institutes of Health